Retour
34
2
Fourchette du Jour
20,87 €
21,24 €
Fourchette 52 Semaines
18,77 €
26,51 €
Volume
671 126
Moyenne 50J / 200J
22,70 €
/
22,86 €
Clôture Précédente
21,52 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 113,5 | 0,4 |
| P/B | 0,0 | 2,9 |
| ROE % | 0,0 | 3,9 |
| Net Margin % | 1,1 | 3,8 |
| Rev Growth 5Y % | 21,8 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
31,00 €
+47.4%
Low: 22,00 €
High: 36,00 €
P/E Prévisionnel
60,8
BPA Prévisionnel
0,35 €
Croissance BPA (est.)
+0,0%
CA Est.
2,4 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,95 €
0,91 € – 0,99 €
|
3,4 B | 1 |
| FY2029 |
0,79 €
0,76 € – 0,83 €
|
3,1 B | 1 |
| FY2028 |
0,65 €
0,51 € – 0,87 €
|
2,9 B | 5 |
Points Clés
Revenue grew 21,75% annually over 5 years — strong growth
Earnings grew 59,33% over the past year
ROE of 0,01% is below average
Debt/Equity of 0,01 — conservative balance sheet
Generating 162,20M in free cash flow
P/E of 113,49 — premium valuation
Croissance
Revenue Growth (5Y)
21,75%
Revenue (1Y)22,26%
Earnings (1Y)59,33%
FCF Growth (3Y)41,80%
Qualité
Return on Equity
0,01%
ROIC0,00%
Net Margin1,08%
Op. Margin1,61%
Sécurité
Debt / Equity
0,01
Current Ratio1,60
Interest Coverage0,00
Valorisation
P/E Ratio
113,49
P/B Ratio0,00
EV/EBITDA-13657,16
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22,26% | Revenue Growth (3Y) | 13,16% |
| Earnings Growth (1Y) | 59,33% | Earnings Growth (3Y) | -0,35% |
| Revenue Growth (5Y) | 21,75% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,12B | Net Income (TTM) | 22,92M |
| ROE | 0,01% | ROA | 0,00% |
| Gross Margin | 9,40% | Operating Margin | 1,61% |
| Net Margin | 1,08% | Free Cash Flow (TTM) | 162,20M |
| ROIC | 0,00% | FCF Growth (3Y) | 41,80% |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 1,60 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 113,49 | P/B Ratio | 0,00 |
| P/S Ratio | 1,23 | PEG Ratio | 2,17 |
| EV/EBITDA | -13657,16 | Dividend Yield | 0,00% |
| Market Cap | 2,60B | Enterprise Value | -467,55B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,12B | 1,74B | 1,66B | 1,36B | 966,22M |
| Net Income | 22,92M | 14,39M | 23,08M | -8,59M | -188,23M |
| EPS (Diluted) | 0,18 | 0,11 | 0,19 | -0,11 | -1,77 |
| Gross Profit | 199,52M | 176,85M | 161,50M | 134,78M | 63,66M |
| Operating Income | 34,24M | 16,98M | 20,65M | -19,12M | -217,44M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,37T | 1,14B | 999,90M | 792,81M | 686,37M |
| Total Liabilities | 578,44B | 452,34M | 392,51M | 273,76M | 236,19M |
| Shareholders' Equity | 737,22B | 635,18M | 561,44M | 499,09M | 426,87M |
| Total Debt | 9,53B | 5,59M | 8,29M | 11,50M | 46,50M |
| Cash & Equivalents | 479,69B | 491,15M | 389,51M | 347,99M | 320,58M |
| Current Assets | 911,00B | 834,82M | 700,80M | 551,96M | 446,68M |
| Current Liabilities | 568,52B | 449,15M | 386,95M | 264,27M | 190,46M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#754 of 1052
#822 of 827
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026